IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached… CISION PRNewswireMay 19, 2026
Yalla Group Limited Announces Unaudited First Quarter 2026 Financial Results DUBAI, UAE, May 19, 2026 /PRNewswire/ — Yalla Group Limited ("Yalla" or… CISION PRNewswireMay 19, 2026
Press ReleaseOMAN'S SOVEREIGN FUND JOINS GLOBAL TOP PERFORMERS AS RETURNS HIT RECORD HIGH Oman Investment Authority reports USD 7.8bn profit and leads worldwide in public… CISION PRNewswireMay 19, 2026
DAVE & BUSTER'S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key… CISION PRNewswireMay 19, 2026
DAVE & BUSTER'S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key… CISION PRNewswireMay 19, 2026
Press ReleaseAramco and Pasqal launch Saudi Arabia's first Quantum Computer and Middle East's first commercial Quantum Computing as a Service platform DHAHRAN, Saudi Arabia, May 19, 2026 /PRNewswire/ — Aramco, one of the… CISION PRNewswireMay 19, 2026
Press ReleaseBybit Launches XUSD Earn Campaign Offering a Competitive APR and 65,000 XUSD Rewards Pool DUBAI, UAE, May 19, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency… CISION PRNewswireMay 19, 2026
Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing NORWALK, Conn., May 19, 2026 /PRNewswire/ — Lifespan Vision Ventures (LVV), an… CISION PRNewswireMay 19, 2026
